As a leading cardiovascular specialty hospital in China, Beijing Anzhen Hospital (affiliated with Capital Medical University) has earned international acclaim for its cutting-edge treatments, world-class physicians, and patient-centered care. Here’s an in-depth look at why it’s a top choice for global patients seeking heart care.
1. Hospital Introduction
Anzhen Hospital is a leading cardiac surgery center in China. It is among the first hospitals approved for heart and lung transplants. With over 4,000 employees, including 600 senior professionals and 900 intermediate – level staff, the hospital has 1,500 beds and 31 operating rooms with advanced air – purification technology.
The hospital excels in cardiovascular care. It has been performing heart, lung, and combined heart – lung transplants for many years. The Thoracic Surgery Department conducted China’s first single – lung transplant in 1995 and double – lung transplant in 1998. Department head Qu Songlei has over 20 years of experience in thoracic surgery and lung transplants. He has published numerous academic papers and won the first prize of the Beijing Science and Technology Progress Award.
The Cardiac Surgery Department includes the Beijing Heart Transplant Center. It specializes in severe valvular heart disease and end – stage heart disease treatment. With 50 beds and 1,000 surgeries per year, it is a top – ranking department in China for heart transplants. It set the record for the longest patient survival time in northern China. The department also performed the world’s first four combined heart, bone marrow, and stem cell transplants.
Xu Meng, founder of the Beijing Heart Transplant and Valvular Surgery Treatment Center, is a renowned heart surgeon. He has completed nearly 10,000 surgeries and published over 100 SCI papers. He is involved in multiple high – level research projects.
2. World-Class Clinical Expertise
Anzhen Hospital stands out for its exceptional volume and success rates in complex cardiovascular procedures:
- Annual Procedures: Over 55,000 cardiac surgeries and 40,000 interventional procedures (e.g., angioplasty, stenting), rivaling top global centers like Cleveland Clinic. Its high volume enables doctors to continuously enhance their skills and accumulate extensive experience in handling various complex conditions.
- Key Specialties:
- Transcatheter Aortic Valve Replacement (TAVR): With 1,200+ cases annually and a 98.2% success rate (vs. 96.5% global average), Anzhen Hospital is at the forefront of this minimally invasive procedure. This technique offers a safer and more effective treatment option for patients with aortic stenosis, especially those who are at high risk for traditional open-heart surgery.
- Coronary Artery Bypass Grafting (CABG): Performing 12,000+ CABG surgeries yearly, Anzhen Hospital provides this life-saving procedure at 1/5 the cost of similar US procedures ($12,000 vs. $75,000+). The hospital’s expertise in CABG ensures optimal outcomes for patients with severe coronary artery disease, helping to improve their quality of life and long-term prognosis.
- Heart Transplantation: As one of China’s first centers for heart transplants, Anzhen Hospital has developed pioneering techniques for end-stage heart failure treatment. Its experienced team has successfully carried out numerous heart transplant surgeries, offering new hope to patients with advanced heart failure.
3. Renowned Physician Team
Anzhen’s doctors are global leaders in their fields:
- Dr. Ma Changsheng 马长生
- A pioneer in cardiac electrophysiology, he established China’s first Atrial Fibrillation (AF) Center, performing over 20,000 ablation procedures with a 98% success rate. His innovative approaches have significantly improved the treatment outcomes for AF patients.
- Developed cryoablation and intra-cardiac echocardiography techniques, reducing complications by 40%. These advanced techniques provide safer and more effective treatment options for patients with cardiac arrhythmias.
- Trains 300+ international cardiologists annually, including specialists from the Middle East and Asia. His efforts have contributed to the dissemination of advanced cardiovascular treatment techniques worldwide.
- Dr. Zeng Yong 曾勇
- A trailblazer in cardiovascular surgery, Dr. Zeng Yong leads Beijing Anzhen Hospital’s efforts in advancing cardiac care through innovative research and clinical excellence.
- Research Breakthroughs: His team debunked PCI myths in thrombocytopenia ACS patients, showing a 45% MACE reduction without heightened bleeding risks. They also confirmed PCI’s safety in high-thrombosis-risk groups, slashing NACE by 53%.
- Clinical Expertise: Dr. Zeng excels in complex cardiovascular surgeries, including CABG and valve replacements, achieving outstanding success rates that enhance patient outcomes.
- Contributions to Medicine: He actively engages in training the next generation of cardiovascular surgeons, sharing his expertise to elevate global standards of care.
4. Notable International Cases
Anzhen Hospital has treated high-profile patients from around the world:
- Middle Eastern Royalty: In 2023, a Saudi royal family member with drug-resistant atrial fibrillation underwent cryoablation at Anzhen Hospital, achieving full recovery without recurrence (case published in Journal of Cardiac Surgery). This successful treatment highlights Anzhen Hospital’s capability to handle complex arrhythmia cases and its reputation among international patients.
- Saudi Patient Success Story: Ahmed Al-Fahim received a heart transplant at Anzhen Hospital for $120,000—85% less than the $800,000 quoted in the US. His post-surgery survival rates met international standards (2023 case report). This case demonstrates the hospital’s high-quality care and cost-effectiveness, making it an attractive option for international patients seeking advanced medical treatment.
- Southeast Asian Dignitaries: Multiple heads of state from Southeast Asia have sought treatment for complex conditions like aortic dissection, leveraging Anzhen Hospital’s minimally invasive hybrid surgeries. The successful treatment of these dignitaries has further enhanced Anzhen Hospital’s international reputation and influence.
5. Cutting-Edge Research & Innovation
Anzhen drives global advancements in cardiovascular medicine:
- Regenerative Therapies: In 2025, the hospital developed engineered exosomes for myocardial repair, increasing heart function by 25% in animal models (featured in Nature and CNN). This breakthrough offers a promising new approach for the treatment of myocardial infarction and other heart diseases, potentially revolutionizing the field of cardiovascular medicine.
- AI in Cardiology: An AI system for sudden cardiac arrest prediction shows 91.3% accuracy, published in a Nature sub-journal. This innovative application of AI technology has the potential to significantly improve the early warning and prevention of sudden cardiac arrest, saving countless lives.
- 3D Printing: Using 3D-printed heart models to plan complex surgeries for congenital heart defects, highlighted in a CNN special report. This advanced technology enables more precise surgical planning and execution, improving outcomes for patients with complex congenital heart diseases.
6. International Patient Services
Anzhen prioritizes seamless care for International patients:
- Multilingual Support: Dedicated international department with 30+ bilingual coordinators, offering services in English, Arabic, and more. The hospital also provides language training for its staff to ensure effective communication with international patients.
- Fast-Track Pathways: VIP green channels allow 48-hour admission-to-surgery for urgent cases, ensuring prompt treatment and care for patients in critical condition.
- Insurance & Cost: Direct billing with 36+ international insurers (US, EU, Middle East).
- The hospital’s transparent and competitive pricing, along with its excellent insurance coverage, makes it an affordable and accessible option for international patients.
- Sample costs: Cardiac bypass: $12,000 (vs. $75,000+ in the US); Valve replacement: $15,000 (vs. $100,000+ in the US).
- Post-Surgery Care: Remote monitoring via IoT devices for international patients, ensuring long-term follow-up. This comprehensive aftercare service helps patients manage their recovery and maintain good health after returning to their home countries.
7. Global Impact & Partnerships
Anzhen’s influence extends beyond China:
- Belt and Road Initiative: Trains 500+ physicians from 15 countries annually, including Indonesia and Saudi Arabia. The hospital also collaborates with medical institutions along the Belt and Road to conduct joint research and exchange programs, promoting the development of cardiovascular medicine in these regions.
- WHO Collaboration: Its treatment protocols for COVID-19 with cardiovascular complications were adopted by the World Health Organization. This recognition highlights the hospital’s significant contribution to global healthcare and its expertise in managing complex medical conditions.
- International Training: Serves as a key training center for global cardiologists, with 300+ overseas doctors trained each year. The hospital’s training programs provide hands-on experience and advanced knowledge in cardiovascular medicine, helping to cultivate a new generation of skilled cardiologists worldwide.
Why Choose Anzhen for Heart Care?
- Expertise: World-leading surgeons with 10,000+ procedures each. The hospital’s team of experts has extensive experience and proficiency in various cardiovascular procedures, ensuring high-quality care and optimal outcomes for patients.
- Innovation: Cutting-edge tech like AI diagnostics and regenerative therapies. Anzhen Hospital’s commitment to innovation keeps it at the forefront of cardiovascular medicine, offering patients access to the latest and most advanced treatment options.
- Affordability: 60–80% cost savings compared to Western hospitals, without compromising quality. The hospital’s reasonable fees make advanced medical treatment accessible to a broader range of patients.
- Accessibility: Beijing’s international flight connections and hospital-provided translation services. The hospital’s location in Beijing, a major international hub, along with its comprehensive translation services, makes it easy for international patients to travel to and receive care at Anzhen Hospital.
Contact Anzhen’s International Center:
- +86-10-6445-6413
- more info: https://medchinaguide.com/china-top-hospitals/beijing/beijing-anzhen-hospital/
(English version available)
If you have any questions about seeking medical treatments in China or need customized medical tourism services, please feel free to contact us. Thank you!
Disclaimer:
This article provides general information about medical tourism in China. It is not intended as medical advice or a substitute for professional consultation. International patients should conduct independent verification of hospitals, surgeons, and procedures, and consult qualified healthcare providers before making treatment decisions. China Medical Tourism Guide assumes no liability for actions taken based on this content.
